Tool for determining responsiveness to anti‐inflamatory agents
IDIVAL has developed a tool for predicting disease severity or prognosis in inflammatory diseases, including Rheumatoid Arthritis, and/or predicting responsiveness to a treatment with anti‐ inflamatory agents, such as anti‐TNFα agents.
The results has been tested in a cohort of more than 1500 patients at Valdecilla Biomedical Research Institute– IDIVAL.
Therapies for inflammatory diseases.
Estado de protección
A patent application covering this technology has been filed through Spanish patent application P201600636.
IDIVAL would like to talk to companies interested in commercializing this tool or in a research cooperation agreement to develop it.
- En desarrollo, Transferible
- Health technology:
- Biotecnología y Diagnóstico Molecular (proteómica, genómica, etc...), Medicamentos - Farma